Diagnosis and treatment of resistant hypertension

References

• Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr., et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206–1252.
   PubMed Web of Science ®Google Scholar
• Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31:1281–1357.
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Clinical Excellence. Hypertension: Clinical management of primary hypertension in adults. http://guidanceniceorguk/CG127/Guidance/pdf/English. 2011;CG127.
   Google Scholar
• Egan BM, Zhao Y, Axon RN, Brzezinski WA, Ferdinand KC. Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to2008. Circulation.2011;124: 1046–1058.
   Google Scholar
• Erdine S, Aran SN. Current status of hypertension control around the world. Clin Expert Hypertens. 2004;26:731–738.
   PubMed Web of Science ®Google Scholar
• Mancia G, Bombelli M, Lanzarotti A, Grassi G, Cesana G, Zanchetti A, et al. Systolic vs diastolic blood pressure control in the hypertensive patients of the PAMELA population. Pressioni Arteriose Monitorate E Loro Associazioni. Arch Int Med. 2002;162:582–586.
   PubMedGoogle Scholar
• Primatesta P, Brookes M, Poulter NR. Improved hypertension management and control: Results from the health survey for England 1998. Hypertension. 2001;38:827–832.
   PubMed Web of Science ®Google Scholar
• Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, Joffres MR, et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension. 2004;43:10–17.
   PubMed Web of Science ®Google Scholar
• Volpe M, Tocci G, Trimarco B, Rosei EA, Borghi C, Ambrosioni E, et al. Blood pressure control in Italy: Results of recent surveys on hypertension. J Hypertens. 2007;25: 1491–1498.
   PubMed Web of Science ®Google Scholar
• Tocci G, Rosei EA, Ambrosioni E, Borghi C, Ferri C, Ferrucci A, et al. Blood pressure control in Italy: Analysis of clinical data from 2005–2011 surveys on hypertension. J Hypertens. 2012;30:1065–1074.
   PubMedGoogle Scholar
• Andersson OK, Almgren T, Persson B, Samuelsson O, Hedner T, Wilhelmsen L. Survival in treated hypertension: Follow up study after two decades. BMJ. 1998;317: 167–171.
   PubMed Web of Science ®Google Scholar
• Benetos A, Thomas F, Bean KE, Guize L. Why cardiovascular mortality is higher in treated hypertensives versus subjects of the same age, in the general population. J Hypertens. 2003;21:1635–1640.
   PubMed Web of Science ®Google Scholar
• Moser M, Setaro JF. Clinical practice. Resistant or difficult-to-control hypertension. N Engl J Med. 2006;355:385–392.
   PubMed Web of Science ®Google Scholar
• Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, et al. Resistant hypertension: Diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation. 2008; 117:e510–e526.
   PubMed Web of Science ®Google Scholar
• Volpe M, Tocci G. Challenging hypertension: How to diagnose and treat resistant hypertension in daily clinical practice. Expert Rev Cardiovasc Ther. 2010;8:811–820.
   PubMedGoogle Scholar
• Bunker J, Callister W, Chang CL, Sever PS. How common is true resistant hypertension?J Hum Hypertens. 2011;25: 137–140.
   PubMedGoogle Scholar
• Burnier M, Wuerzner G, Struijker-Boudier H, Urquhart J. Measuring, analyzing, and managing drug adherence in resistant hypertension. Hypertension. 2013;62:218–225.
   PubMed Web of Science ®Google Scholar
• Pedrosa RP, Drager LF, Gonzaga CC, Sousa MG, de Paula LK, Amaro AC, et al. Obstructive sleep apnea: The most common secondary cause of hypertension associated with resistant hypertension. Hypertension. 2011;58:811–817.
   PubMed Web of Science ®Google Scholar
• Mezzetti A, Pierdomenico SD, Costantini F, Romano F, Bucci A, Di Gioacchino M, et al. White-coat resistant hypertension. Am J Hypertens. 1997;10:1302–1307.
   PubMed Web of Science ®Google Scholar
• Veglio F, Rabbia F, Riva P, Martini G, Genova GC, Milan A, et al. Ambulatory blood pressure monitoring and clinical characteristics of the true and white-coat resistant hypertension. Clin Exp Hypertens. 2001;23:203–211.
   PubMed Web of Science ®Google Scholar
• Ohkubo T, Asayama K, Kikuya M, Metoki H, Hoshi H, Hashimoto J, et al. How many times should blood pressure be measured at home for better prediction of stroke risk? Ten-year follow-up results from the Ohasama study. J Hypertens. 2004;22:1099–1104.
   PubMed Web of Science ®Google Scholar
• Mancia G, Facchetti R, Bombelli M, Grassi G, Sega R. Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension. 2006;47:846–853.
   PubMed Web of Science ®Google Scholar
• Sega R, Facchetti R, Bombelli M, Cesana G, Corrao G, Grassi G, et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: Follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation. 2005;111:1777–1783.
   PubMed Web of Science ®Google Scholar
• Fagard RH, Van Den Broeke C, De Cort P. Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice. J Hum Hypertens. 2005;19:801–807.
   PubMed Web of Science ®Google Scholar
• Stergiou GS, Baibas NM, Kalogeropoulos PG. Cardiovascular risk prediction based on home blood pressure measurement: The Didima study. J Hypertens. 2007;25:1590–1596.
   PubMed Web of Science ®Google Scholar
• Pickering TG, James GD, Boddie C, Harshfield GA, Blank S, Laragh JH. How common is white coat hypertension?JAMA. 1988;259:225–228.
   PubMed Web of Science ®Google Scholar
• des Combes BJ, Porchet M, Waeber B, Brunner HR. Ambulatory blood pressure recordings. Reproducibility and unpredictability. Hypertension. 1984;6:110–114.
   Web of Science ®Google Scholar
• Stergiou GS, Skeva, II, Baibas NM, Kalkana CB, Roussias LG, Mountokalakis TD. Diagnosis of hypertension using home or ambulatory blood pressure monitoring: Comparison with the conventional strategy based on repeated clinic blood pressure measurements. J Hypertens. 2000;18:1745–1751.
   PubMed Web of Science ®Google Scholar
• Redon J, Campos C, Narciso ML, Rodicio JL, Pascual JM, Ruilope LM. Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: A prospective study. Hypertension. 1998;31:712–718.
   PubMed Web of Science ®Google Scholar
• Salles GF, Cardoso CR, Muxfeldt ES. Prognostic influence of office and ambulatory blood pressures in resistant hypertension. Arch Int Med. 2008;168:2340–2346.
   PubMed Web of Science ®Google Scholar
• Persell SD. Prevalence of resistant hypertension in the United States, 2003–2008. Hypertension.2011;57:1076–1080.
   Google Scholar
• de la Sierra A, Segura J, Banegas JR, Gorostidi M, de la Cruz JJ, Armario P, et al. Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension. 2011;57:898–902.
   PubMed Web of Science ®Google Scholar
• Oikawa T, Obara T, Ohkubo T, Kikuya M, Asayama K, Metoki H, et al. Characteristics of resistant hypertension determined by self-measured blood pressure at home and office blood pressure measurements: The J-HOME study. J Hypertens. 2006;24:1737–1743.
   PubMed Web of Science ®Google Scholar
• Parati G, Stergiou GS, Asmar R, Bilo G, de Leeuw P, Imai Y, et al. European Society of Hypertension guidelines for blood pressure monitoring at home: A summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J Hypertens. 2008;26:1505–1526.
   PubMed Web of Science ®Google Scholar
• O’Brien E, Parati G, Stergiou G, R A, Beilin L, Bilo G, et al. European Society of Hypertension Position Paper on Ambulatory Blood Pressure Monitoring. J Hypertens. 2013;31: 1731–1768.
   PubMed Web of Science ®Google Scholar
• de la Sierra A, Banegas JR, Oliveras A, Gorostidi M, Segura J, de la Cruz JJ, et al. Clinical differences between resistant hypertensives and patients treated and controlled with three or less drugs. J Hypertens. 2012;30:1211–1216.
   PubMed Web of Science ®Google Scholar
• Muxfeldt ES, Bloch KV, Nogueira Ada R, Salles GF. True resistant hypertension: Is it possible to be recognized in the office?Am J Hypertens. 2005;18:1534–1540.
   PubMed Web of Science ®Google Scholar
• Oliveras A, Armario P, Hernandez-Del Rey R, Arroyo JA, Poch E, Larrousse M, et al. Urinary albumin excretion is associated with true resistant hypertension. J Hum Hypertens. 2010;24:27–33.
   PubMed Web of Science ®Google Scholar
• Waeber B, Brunner HR, Metry JM. Compliance with antihypertensive treatment: Implications for practice. Blood Press. 1997;6:326–331.
   PubMedGoogle Scholar
• Dezii CM. A retrospective study of persistence with single-pill combination therapy vs. concurrent two-pill therapy in patients with hypertension. Manag Care. 2000;9 Suppl:2–6.
   Google Scholar
• Chrysant SG. Single-pill triple-combination therapy: An alternative to multiple-drug treatment of hypertension. Postgrad Med. 2011;123:21–31.
   PubMed Web of Science ®Google Scholar
• Waeber B, Feihl F, Ruilope LM. Fixed-dose combinations as initial therapy for hypertension: A review of approved agents and a guide to patient selection. Drugs. 2009;69:1761–1776.
   PubMed Web of Science ®Google Scholar
• Ogedegbe G, Schoenthaler A. A systematic review of the effects of home blood pressure monitoring on medication adherence. J Clin Hypertens. 2006;8:174–180.
   PubMedGoogle Scholar
• Chapman N, Dobson J, Wilson S, Dahlof B, Sever PS, Wedel H, et al. Effect of spironolactone on blood pressure in subjects with resistant hypertension. Hypertension. 2007;49:839–845.
   PubMed Web of Science ®Google Scholar
• Vaclavik J, Sedlak R, Plachy M, Navratil K, Plasek J, Jarkovsky J, et al. Addition of spironolactone in patients with resistant arterial hypertension (ASPIRANT): A randomized, double-blind, placebo-controlled trial. Hypertension. 2011; 57:1069–1075.
   PubMed Web of Science ®Google Scholar
• Brunner HR, Nussberger J, Waeber B. Responsiveness of renin secretion: A key mechanism in the maintenance of blood pressure. J Hypertens. 1986;4:s89–94.
   Google Scholar
• Hackam DG, Duong-Hua ML, Mamdani M, Li P, Tobe SW, Spence JD, et al. Angiotensin inhibition in renovascular disease: A population-based cohort study. Am Heart J. 2008;156:549–555.
   PubMed Web of Science ®Google Scholar
• Hanselin MR, Saseen JJ, Allen RR, Marrs JC, Nair KV. Description of antihypertensive use in patients with resistant hypertension prescribed four or more agents. Hypertension. 2011;58:1008–1013.
   PubMed Web of Science ®Google Scholar